RT Journal Article
SR Electronic
T1 Interrelations of Serum Uric Acid, Beta-Cell Function, and Insulin Resistance in Indian Cohort: A Comprehensive Analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.11.18.24317374
DO 10.1101/2024.11.18.24317374
A1 Thummala, Sabitha
A1 Kruthi, Nithya
A1 Fatima, Sarah
A1 Ghori, Junaid Ahmed Khan
A1 Saikia, Katherine
A1 Balamurali, AR
A1 Ranganathan, Rahul
YR 2024
UL http://medrxiv.org/content/early/2024/11/19/2024.11.18.24317374.abstract
AB Background Hyperuricemia, characterised by elevated levels of serum uric acid (SUA), has been linked to an increased risk of metabolic disorders, including type 2 diabetes. Understanding the relationship between SUA, beta-cell function, and insulin resistance is crucial for elucidating the pathophysiology of these conditions, especially in the Indian population, where such data is limited.Objective This study aimed to explore the interrelations between serum uric acid levels, beta-cell function, and insulin resistance in an Indian cohort.Methods A cross-sectional study was conducted involving a representative sample of adults from an Indian population. Participants were stratified into sex-specific SUA quartiles. Key measurements included BMI, serum creatinine, lipid profiles, fasting insulin, HOMA1-B (beta-cell function), and HOMA1-IR (insulin resistance). Partial correlation coefficients were calculated to assess the associations between SUA and various metabolic parameters.Results Significant differences were observed across SUA quartiles in terms of age, BMI, serum creatinine, HDL cholesterol, LDL cholesterol, triglycerides, total cholesterol, fasting insulin, HOMA1-B, and HOMA1-IR (all p-values < 0.05). Higher SUA levels were associated with increased BMI, serum creatinine, triglycerides, fasting insulin, HOMA1-B, and HOMA1-IR. Additionally, partial correlation analysis revealed positive correlations between SUA and BMI (r=0.065, p=0.026), fat mass (r=0.065, p=0.026), serum creatinine (r=0.277, p<0.001), triglycerides (r=0.084, p=0.004), fasting insulin (r=0.130, p<0.001), and HOMA1-B (r=0.078, p=0.008). Negative correlations were found between SUA and vitamin B12 (r=-0.117, p=0.000071), GFR (r=-0.113, p<0.001), total cholesterol (r=-0.068, p=0.021), LDL cholesterol (r=-0.080, p=0.006), HDL cholesterol (r=-0.071, p=0.016), and HbA1c (r=-0.170, p<0.001).Conclusions Elevated serum uric acid levels are significantly associated with increased beta-cell function and insulin resistance among Indian adults. These findings suggest that hyperuricemia could be an early marker for metabolic dysfunction, highlighting the need for early intervention strategies in this population. Further longitudinal studies are warranted to establish causal relationships and to explore the potential benefits of uric acid-lowering therapies in preventing metabolic diseases.Trial registration Not applicable.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunded by Answer Genomics Pvt Ltd.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical Considerations: Obtained ethical approval from Answergenomics Ethical Research Committee (AERC) relevant institutional review boards. Adhered to ethical guidelines for human research, ensuring participant confidentiality and privacy. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors